364 related articles for article (PubMed ID: 9082442)
1. [Comparison of serum concentrations of once and twice daily administration of ultra-retard theophylline in school children with bronchial asthma].
Liebke C; Niggemann B; Wahn U
Pneumologie; 1996 Nov; 50(11):752-5. PubMed ID: 9082442
[TBL] [Abstract][Full Text] [Related]
2. [Comparison of two long-acting theophylline preparations in daily evening administration].
Holzer R
Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
[TBL] [Abstract][Full Text] [Related]
3. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
[TBL] [Abstract][Full Text] [Related]
4. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
5. Theophylline levels after single daily and divided dosing of a once-a-day theophylline preparation in asthmatic children.
Boner AL; Sette L; Vallone G; Plebani M; Messori A
Ann Allergy; 1989 Feb; 62(2):149-53. PubMed ID: 2919803
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of growth hormone secretion by theophylline in asthmatic children].
Baum WF; Klöditz E; Schneyer U
Pneumologie; 1996 Mar; 50(3):238-41. PubMed ID: 8919920
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and pharmacodynamics of twice-daily unequal administration of theophylline retard pellets in children of various age groups].
Berdel D; von Berg A; Reinhardt D; Heimann G; Steinijans VW; Sauter R
Pneumologie; 1991 Nov; 45 Suppl 4():863-6. PubMed ID: 1812481
[TBL] [Abstract][Full Text] [Related]
8. Biopharmaceutic characteristics of a new extended-release theophylline formulation (Uni-Dur).
Oosterhuis B; Brannan MD; Groen H; Peeters PA; Hempenius J; Radwanski E; Nomeir AA; Affrime MB; Jonkman JH
Ann Allergy Asthma Immunol; 1995 Aug; 75(2):157-61. PubMed ID: 7648380
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of a slow-release theophylline capsule given twice daily to preschool children with chronic asthma: comparison with liquid theophylline.
Sallent J; Hill M; Stecenko A; McKenzie M; Hendeles L
Pediatrics; 1988 Jan; 81(1):116-20. PubMed ID: 3336577
[TBL] [Abstract][Full Text] [Related]
10. [Value of a daily dose of theophylline in the treatment of nocturnal asthma].
Godard P; Kleisbauer JP; Muir JF; Paramelle B; Mazoyer F
Rev Pneumol Clin; 1986; 42(5):262-5. PubMed ID: 3809874
[TBL] [Abstract][Full Text] [Related]
11. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
[TBL] [Abstract][Full Text] [Related]
12. Effect of once daily and twice daily sustained release theophylline formulations on daytime variation of bronchial hyperresponsiveness in asthmatic patients.
Ferrari M; Olivieri M; Lampronti G; Bonazza L; Biasin C; Nacci P; Talamini G; Lo Cascio V
Thorax; 1997 Nov; 52(11):969-74. PubMed ID: 9487345
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic comparison of a once-daily and twice-daily theophylline delivery system.
González MA; Kisicki J; Straughn AB
Clin Ther; 1994; 16(4):686-92. PubMed ID: 7982257
[TBL] [Abstract][Full Text] [Related]
14. Steady-state pharmacokinetics of a once-daily theophylline formulation (Euphylong) when given twice daily.
Götz J; Sauter R; Steinijans VW; Jonkman JH
Int J Clin Pharmacol Ther; 1994 Apr; 32(4):168-73. PubMed ID: 8032575
[TBL] [Abstract][Full Text] [Related]
15. Apparent decrease in population clearance of theophylline: implications for dosage.
Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
[TBL] [Abstract][Full Text] [Related]
16. [Continuous treatment of asthma in children with theophylline retard].
de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
[TBL] [Abstract][Full Text] [Related]
17. [Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline--comparison of effectiveness and tolerance].
Ukena D; Koper I; Braun H; Leutz M; Schlimmer P; Sybrecht GW
Pneumologie; 1997 Mar; 51(3):317-23. PubMed ID: 9173422
[TBL] [Abstract][Full Text] [Related]
18. Variations in theophylline concentrations detected by 24-hour saliva concentration profiles in ambulatory children with asthma.
Tal A; Aviram M; Gorodischer R
J Allergy Clin Immunol; 1990 Aug; 86(2):238-43. PubMed ID: 2384651
[TBL] [Abstract][Full Text] [Related]
19. Intersubject variability of serum theophylline concentration after single dose of uncoated controlled release theophylline tablet administration in asthmatic patients.
Raj NS; Guleria R; Misra A; Pande JN
Indian J Chest Dis Allied Sci; 1997; 39(3):143-7. PubMed ID: 9357147
[TBL] [Abstract][Full Text] [Related]
20. [Clinical use of theophylline retard Oranienburg].
Slapke J; Hummel S; Wilke A; Wenz W; Meister W; Förster R; Wiesner B; Rentsch E; Nussbücker B
Z Erkr Atmungsorgane; 1988; 170(1):49-53. PubMed ID: 3291417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
